What is better WSO2 Identity Server or iStart? The perfect Identity Management Software is a solution that can handle your company’s specific demands. It is possible to determine which alternative works really with your enterprise if you assess different products before you decide which one is the best.
For example, WSO2 Identity Server and iStart are scored at 8.8 and 8.0, respectively, for general quality and performance. Similarly, WSO2 Identity Server and iStart have a user satisfaction rating of 91% and 94%, respectively, which suggests the general feedback they get from customers. Better yet, reach put to a current user of the software and solicit their comments concerning the application in question.
As of now, the most popular services in our Identity Management Software category are: Forefront Identity Manager, Okta Identity Cloud, Oracle Identity Management.
You should note that even though both WSO2 Identity Server and iStart may provide a reliable array of features each software could be designed for a different company size. If you are studying different apps you may want to give some attention to a company size they are aimed at. Certain elements might scale up well for big enterprises but if you own a small or mid-sized company it’s frequently better to stay away from paying for advanced features that you may never actually use.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
